Last reviewed · How we verify
Procalamine (PHOSPHORIC ACID)
At a glance
| Generic name | PHOSPHORIC ACID |
|---|---|
| Sponsor | B Braun |
| Drug class | Non-Standardized Fungal Allergenic Extract [EPC] |
| Modality | Small molecule |
| Therapeutic area | Bone |
| Phase | FDA-approved |
| First approval | 1971 |
Approved indications
- Nutritional support
Common side effects
Key clinical trials
- Comparison of Two Minimally Invasive Approaches for Masking Molar-Incisor Hypomineralization Opacities (NA)
- Two-Year Clinical Performance of Self-Cured Resin Composite in Comparison to Light-Cured Bioactive Resin Composite in Restoring Occlusal Cavities of Posterior Teeth. (NA)
- Pacritinib With Aza for Upfront Myelodysplastic Syndrome (PHASE1,PHASE2)
- Evaluating Universal Adhesives in Cervical Lesions (NA)
- HEMA-free Universal Adhesives for Restoring Non-carious Cervical Lesions (NA)
- Performance of Reinforced 3D-Printed Versus Direct Bulk-Filled Resin Composites for Restoring Extensive Class II Cavities in Vital Molars (NA)
- Injection Molding Technique: A Minimally Invasive Management for Enamel Hypoplasia Affecting Permanent Anterior Teeth in Children (PHASE4)
- Comparison of Conventional and Cu-NiTi Archwires Regarding Clinical Efficiency and Pain Intensity Using Prostaglandin E2 Biomarker During Alignment and Leveling (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Procalamine CI brief — competitive landscape report
- Procalamine updates RSS · CI watch RSS
- B Braun portfolio CI